Press Releases

Thermo Fisher and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer

Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher's next-generation sequencing (NGS)-based Oncomine Dx Target Test. The CDx will be designed to...

Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has signed an agreement with ViralClear Pharmaceuticals, Inc. (ViralClear), a subsidiary of...

Fresenius Kabi Expands MicroVault Packaging to include Simplist Morphine Injection, USP Ready-to-Administer Prefilled Syringes

Fresenius Kabi announced the availability in the United States of Simplist® Morphine Sulfate Injection, USP 2 mg per 1 mL and 4 mg per 1 mL ready-to-administer prefilled syringes in MicroVault packaging. MicroVault is next-generation packaging designed and manufactured in...

Symbiosis and AstraZeneca Sign Supply Agreement for Sterile Manufacture of COVID-19 Vaccine for Clinical Trials

Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222 for AstraZeneca sponsored clinical trials. Under...

CAS Makes Commitment to Enhance Laboratory Safety by Partnering with the Pistoia Alliance for Chemical Safety Library

CAS, a division of the American Chemical Society specializing in scientific information solutions, and the Pistoia Alliance, a global, not-for-profit members’ organization that works to lower barriers to innovation in life sciences R&D, announced the signing of an agreement...

iNova Pharmaceuticals announces the launch of iPitch 2020

Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020. iPitch is a collaborative crowdsourcing program that allows product and packaging...

Hetero announces the approval and launch of first generic COVIFOR in India for the treatment of Covid-19

Hetero, one of India’s leading generic pharmaceutical companies, announced that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’ from the Drug Controller General of India (DCGI) for the treatment of Covid-19. Hetero’s generic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read